The Aspen Group has a proud heritage dating back more than 160 years and today its products reach approximately 150 countries. Aspen is the largest pharmaceutical company listed on the JSE Limited South Africa's stock exchange and is included in its Top 40 Index. The largest pharmaceutical company in Africa, Aspen has an extensive global presence and is ranked amongst the top 10 generic pharmaceutical producers globally.

Aspen's expansion strategy has, to date, focused on developing a presence in the so-called emerging pharmaceutical markets where patients are often responsible for their own healthcare costs and where the future demand for low cost, high quality generic alternatives is rising. Aspen is able to respond to the developing healthcare needs in these territories with its broad range portfolio which offers essential but affordable medicines to patients. Regional product portfolios are carefully developed to address key disease profiles in each territory and to support the healthy wellbeing of millions of patients who rely on Aspen's products.

Aspen's strength lies in its understanding of the dynamic markets in which the Group operates and identifying and pursuing opportunities that align with the Group's vision and strategy.

South Africa
As the market leader in the private and public pharmaceutical sectors in South Africa, Aspen is well positioned to extend the solid performance achieved in the past year through organic growth. Ongoing investment will ensure Aspen continues to excel in its supply of high quality, affordable products into the domestic and international markets.

Full Name of Company: Aspen Pharmacare Holdings Limited
Nature of Business: A global supplier of branded and generic pharmaceutical products as well as consumer and nutritional products in selected territories
Products: Aspen provides an extensive basket of products which enable the treatment of a broad spectrum of acute and chronic conditions experienced throughout all stages of life
Date Established: 1850 with Lennon Limited
Subsidiaries: 26 manufacturing facilities at 18 pharmaceutical manufacturing sites on six continents
Customer Base: Private and public sector
No of Employees: 10000
B-BBEE Status: Level 3

Aspen Pharmacare

Posted on September 15, 2014 in SA Investing
In 1998, Stephen Saad and Gus Attridge took their ambitions public through the reverse takeover by their year-old business into JSE-listed M... continue reading ›